In hypertensive patients with diabetes, the effectiveness of renin-angiotensin system (RAS) inhibitors in improving mortality, cardiovascular events, and renal ...
The renin-angiotensin-aldosterone system (RAAS) plays a central role in blood pressure (BP) control through its downstream components including angiotensin II and aldosterone. However, recent data ...
The argument was elegant in its simplicity. Patients with high levels of renin had a vasoconstriction type of hypertension that was driven primarily by the actions of the renin-angiotensin system on ...
Efficacy of Renin-Angiotensin System Inhibitors in Long-Term Oncologic Outcomes of Patients With Stage II/III Colon Cancer and Hypertension: A Target Trial Emulation Several design features strengthen ...
Hypertension develops early in patients with autosomal dominant polycystic kidney disease (ADPKD) and is associated with disease progression. The renin–angiotensin–aldosterone system (RAAS) is ...
Initial evidence of the existence of renin, which is an angiotensinogenase enzyme secreted by the kidney, was presented to the medical community more than 100 years ago. Nevertheless, the significance ...
a Multivariate model adjusting for cancer therapy including antimetabolites, Vascular endothelial growth factors inhibitors, taxanes, tyrosine kinase inhibitors, monoclonal antibodies, vinca alkaloids ...
A 24-month real-world cohort study of 121 patients with non-diabetic chronic kidney disease found that finerenone initiation ...
In patients with mild or moderate chronic kidney disease, renin–angiotensin system inhibitors have improved outcomes, but less evidence supports their use in advanced CKD. New research findings are ...
A twelve-week acupuncture protocol in hypertensive rats lowered blood pressure, restored a neuroprotective deacetylase in the ...
University of Virginia School of Medicine researchers have discovered how certain cells have the amazing ability to transform their function to help our bodies control our blood pressure. These cells ...
Angiotensin receptor blockers are antihypertensive medicines used to treat high blood pressure. They act as vasodilators, widening the blood vessels (vasodilation) and reducing blood pressure. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results